Better reimbursement programs can improve access to cancer clinical trials
New research reveals that participating in cancer clinical trials can cause financial burdens that are shaped by both socioeconomic and logistical factors.
Read original article on The Medical News →Related news
-
Childhood cancer cells shape-shift to spread without genetic mutations
United Kingdom
-
AI assesses what really matters to people in health care—well-being
United Kingdom
-
Early trial results suggest potential new treatment for stiff person syndrome
United Kingdom
-
US youths see nearly 4,000 food marketing messages on digital media each year
United Kingdom
-
A brief history of the food pyramid – and its many false starts
Australia
-
Fish Stocks Thrive Thanks to This Pink Seaweed and Locals Who Protected It
United Kingdom
-
It takes a neighborhood to keep kids active
United Kingdom
-
Two-year study will examine how gender-affirming hormone therapy affects energy use and blood vessel function
United Kingdom